3B Blackbio Dx Limited reported earnings results for the full year ended March 31, 2024. For the full year, the company reported sales was INR 741.25 million compared to INR 618.36 million a year ago. Revenue was INR 866.57 million compared to INR 690.62 million a year ago.

Net income was INR 327.35 million compared to INR 260.73 million a year ago. Basic earnings per share from continuing operations was INR 37.46 compared to INR 34.62 a year ago. Diluted earnings per share from continuing operations was INR 37.46 compared to INR 34.62 a year ago.